UK markets closed

Immuneering Corporation (IMRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4300+0.0200 (+1.42%)
At close: 04:00PM EDT
1.4300 0.00 (0.00%)
After hours: 04:27PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-54,175
-53,472
-50,514
-33,536
-17,040
-
Depreciation & amortisation
365.765
352.083
277.252
159.072
79.305
-
Deferred income taxes
-
-
0
-307.485
0
-
Stock-based compensation
5,928
5,727
4,064
1,803
1,087
-
Change in working capital
-1,568
-974.641
1,717
900.416
1,253
-
Accounts receivable
1.046
12.417
233.623
279.713
-290.17
-
Accounts payable
-558.57
-1,107
1,760
-130.398
1,186
-
Other working capital
-50,394
-49,311
-44,844
-30,912
-14,674
-
Other non-cash items
-
-
-
-
-
1,476
Net cash provided by operating activities
-50,042
-48,969
-44,101
-30,851
-14,621
-
Cash flows from investing activities
Investments in property, plant and equipment
-352.231
-342.746
-742.483
-60.786
-53.415
-
Purchases of investments
-
-44,661
-50,105
-75,626
0
-
Sales/maturities of investments
54,730
52,300
92,678
0
-
-
Net cash used for investing activities
9,717
7,296
41,831
-75,616
-53.415
-
Cash flows from financing activities
Common stock issued
-
28,200
0
120,319
0
-
Other financing activities
-
-203.768
-281.375
-2,124
-
-56.242
Net cash used provided by (used for) financing activities
29,182
28,441
19.004
144,265
37,982
-
Net change in cash
-11,143
-13,231
-2,251
37,798
23,308
-
Cash at beginning of period
77,430
72,637
74,888
37,090
13,782
-
Cash at end of period
66,287
59,406
72,637
74,888
37,090
-
Free cash flow
Operating cash flow
-50,042
-48,969
-44,101
-30,851
-14,621
-
Capital expenditure
-352.231
-342.746
-742.483
-60.786
-53.415
-
Free cash flow
-50,394
-49,311
-44,844
-30,912
-14,674
-